HOME › DRUGS › TUCATINIB
ACTIVE SUBSTANCE / INN

TUCATINIB

Brand name(s): Tukysa, TUKYSA
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA213411
Breast Neoplasms;Neoplasm Metastasis
ACTIVE SUBSTANCE
Tucatinib
REGULATORS
FDA · EMA
SPONSORS / MAH
SEAGEN, Pfizer Europe MA EEIG
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TUKYSANDA213411SEAGENPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TukysaPfizer Europe MA EEIGAuthorised11/02/2021Breast Neoplasms;Neoplasm Metastasis

FULL INTELLIGENCE ON TUCATINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →